FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 53 filers reported holding FENNEC PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $96,000 | -16.5% | 15,500 | 0.0% | 0.00% | – |
| Q4 2020 | $115,000 | +23.7% | 15,500 | 0.0% | 0.00% | – |
| Q3 2020 | $93,000 | -27.9% | 15,500 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $129,000 | – | 15,500 | – | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q1 2019 | $16,000 | -23.8% | 3,300 | 0.0% | 0.00% | – |
| Q4 2018 | $21,000 | -22.2% | 3,300 | 0.0% | 0.00% | – |
| Q3 2018 | $27,000 | -20.6% | 3,300 | 0.0% | 0.00% | – |
| Q2 2018 | $34,000 | – | 3,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Solas Capital Management, LLC | 960,000 | $8,016,000 | 7.40% |
| Sonic Fund II, L.P. | 1,634,689 | $13,650,000 | 6.79% |
| Southpoint Capital Advisors LP | 4,077,214 | $34,045,000 | 0.83% |
| 683 Capital Management, LLC | 1,110,000 | $9,269,000 | 0.74% |
| Opaleye Management Inc. | 171,000 | $1,428,000 | 0.29% |
| Avoro Capital Advisors LLC | 1,670,000 | $13,945,000 | 0.28% |
| Eventide Asset Management | 1,120,000 | $9,352,000 | 0.20% |
| CADENCE CAPITAL MANAGEMENT LLC | 153,556 | $1,282,000 | 0.19% |
| Hartford Financial Management Inc. | 49,548 | $414,000 | 0.13% |
| Granahan Investment Management | 245,377 | $2,049,000 | 0.07% |